Biomarker study for early-stage lung cancer spread
Part of Cancer, Lungs & breathing clinical trials.
This study looks for biological markers (biomarkers) in your cancer tissue to help predict whether the tumor might spread through air spaces. It aims to better understand your cancer and may help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been newly diagnosed with early-stage lung adenocarcinoma (a common type of lung cancer).
- You have NOT yet received treatment for this lung cancer.
- You do not have another active cancer.
- You do not have liver disease, including hepatitis.
- You do not have an autoimmune disease or inflammatory bowel disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at inherited genetic changes in people with a type of lung cancer called lung adenocarcinoma. The goal is to find gene variants linked to the disease, which may help guide future treatment decisions.
This study is looking at certain substances in the fluid around the lungs (pleural effusion) of people with lung adenocarcinoma. It may help doctors understand this condition better and find new ways to treat it.
This study looks at how lung cancer spreads in people with early-stage non-small cell lung cancer. It may help doctors better understand the disease and improve treatment.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This study looks back at medical records and CT scans of people with early-stage lung cancer to find patterns that help predict if cancer cells may spread through air spaces. This could help doctors plan better treatments for patients like you.
This study looks for cancer cells that travel through the blood or spread through air spaces in the lungs of people with early-stage lung cancer. The goal is to understand how these cells affect the disease, and it may help doctors plan better treatment in the future.
Hear when a new Lung Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.